Cyclophosphamide

製品コードS1217 バッチS121702

印刷

化学情報

 Chemical Structure Synonyms NSC 26271,Endoxan, Cytoxan, Neosar, Procytox, Revimmune, Cytophosphane Storage
(From the date of receipt)
3 years -20°C powder
1 years -80°C in solvent
化学式

C7H15Cl2N2O2P

分子量 261.09 CAS No. 50-18-0
Solubility (25°C)* 体外 DMSO 52 mg/mL (199.16 mM)
Water 52 mg/mL (199.16 mM)
Ethanol 52 mg/mL (199.16 mM)
体内 (毎回新しく調製した物を用意してください)
Homogeneous suspension
CMC-NA
≥5mg/ml Taking the 1 mL working solution as an example, add 5 mg of this product to 1 ml of CMC-Na solution, mix evenly to obtain a homogeneous suspension with a final concentration of 5 mg/ml.
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

溶剤液(一定の濃度)を調合する

生物活性

製品説明 Cyclophosphamide(NSC 26271,Endoxan, Cytoxan, Neosar, Procytox, Revimmune, Cytophosphane) is a nitrogen mustard alkylating agent from the oxazophorines group.
in vivo

Cyclophosphamide is an alkylating agent with cytotoxic and immunosuppressive activities. This compound requires enzymatic and chemical activation to release active phosphoramide mustard which produces the interstrand and intrastrand DNA crosslinks at guanine N-7 positions. It exerts its cytotoxic activity by inhibiting nuclear DNA replication. The mechanism of this compound-induced immunosuppression is possibly due to direct cytotoxic effect of the drug on immunocompetent lymphocytes, particulafly those that have undergone antigenic differentiation and division. This chemical has its greatest effect on B cells with relative T cell-sparing effect. [1] Trials in various tumor-bearing animals confirmed this in vivo activity and demonstrated fairly potent antitumor effect. This agent, in combination with other antineoplastic agents, is used for the treatment of various cancers, including breast, lymphoid and pediatric malignancies. [2]

プロトコル(参考用のみ)

参考

  • https://pubmed.ncbi.nlm.nih.gov/6392368/
  • https://pubmed.ncbi.nlm.nih.gov/19786984/

カスタマーフィードバック

Data from [Data independently produced by Cancer Res, 2012, 72(23):6200-8]

Selleckの高級品が、幾つかの出版された研究調査結果(以下を含む)で使われた:

Dynamin-1 is a potential mediator in cancer-related cognitive impairment [ Neurotherapeutics, 2025, 22(1):e00480] PubMed: 39516074
Characterization of a pleomorphic rhabdomyosarcoma cell line [ Sci Rep, 2025, 15(1):2893] PubMed: 39843506
Panobinostat Synergizes with Chemotherapeutic Agents and Improves Efficacy of Standard-of-Care Chemotherapy Combinations in Ewing Sarcoma Cells [ Cancers (Basel), 2024, 16(21)3565] PubMed: 39518006
Mucin-1-Targeted Chimeric Antigen Receptor T Cells Are Effective and Safe in Controlling Solid Tumors in Immunocompetent Host [ J Immunother, 2024, 10.1097/CJI.0000000000000505] PubMed: 38270462
Exploring miRNA‑target gene profiles associated with drug resistance in patients with breast cancer receiving neoadjuvant chemotherapy [ Oncol Lett, 2024, 27(4):158] PubMed: 38426156
ATR/Chk1 interacting lncRNA modulates DNA damage response to induce breast cancer chemoresistance [ Cell Insight, 2024, 3(5):100183] PubMed: 39148723
Adipose-derived stem cells promote the repair of chemotherapy-induced premature ovarian failure by inhibiting granulosa cells apoptosis and senescence [ Stem Cell Res Ther, 2023, 14(1):75] PubMed: 37038203
PTC596-Induced BMI-1 Inhibition Fights Neuroblastoma Multidrug Resistance by Inducing Ferroptosis [ Antioxidants (Basel), 2023, 13(1)3] PubMed: 38275623
Mitochondrial adaptation decreases drug sensitivity of persistent triple negative breast cancer cells surviving combinatory and sequential chemotherapy [ Neoplasia, 2023, 10.1016/j.neo.2023.100949] PubMed: 37956532
Novel model of triple-negative breast cancer produces viable circulating tumor cells and rapid lung metastasis for functional testing in vivo [ Neoplasma, 2023, 10.4149/neo_2023_230404N185] PubMed: 37789779

長期の保管のために-20°Cの下で製品を保ってください。

人間や獣医の診断であるか治療的な使用のためにでない。

各々の製品のための特定の保管と取扱い情報は、製品データシートの上で示されます。大部分のSelleck製品は、推薦された状況の下で安定です。製品は、推薦された保管温度と異なる温度で、時々出荷されます。長期の保管のために必要とされてそれと異なる温度で、多くの製品は、短期もので安定です。品質を維持するが、夜通しの積荷のために最も経済的な貯蔵状況を用いてあなたの送料を保存する状況の下に、製品が出荷されることを、我々は確実とします。製品の受領と同時に、製品データシートの上で貯蔵推薦に従ってください。